Clinical Trials Browser

Interventional × Adenocarcinoma × eribulin × Clear all

NCT02404506 2021-09-29

Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer

Phase 2 Terminated

Adenocarcinoma, Breast Neoplasms